Clinical Trials
2 trialsNCT06342037 2024-09-19
TONIC-3
The Netherlands Cancer Institute
Phase 2 Recruiting
NCT04584112 2023-03-15
A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer
Hoffmann-La Roche
Phase 1 Completed